| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US10647649 | DERMAVANT SCI | Process for preparing tapinarof |
Nov, 2038
(14 years from now) | |
| US11597692 | DERMAVANT SCI | Process for preparing tapinarof |
Nov, 2038
(14 years from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11612573 | DERMAVANT SCI | Topical pharmaceutical compositions |
May, 2036
(12 years from now) | |
| US11458108 | DERMAVANT SCI | Topical pharmaceutical compositions |
May, 2036
(12 years from now) | |
| US10195160 | DERMAVANT SCI | Topical pharmaceutical compositions |
May, 2036
(12 years from now) | |
| US11622945 | DERMAVANT SCI | Topical pharmaceutical compositions |
May, 2036
(12 years from now) | |
| US10426743 | DERMAVANT SCI | Topical pharmaceutical compositions |
May, 2036
(12 years from now) | |
| US11617724 | DERMAVANT SCI | Topical pharmaceutical compositions |
May, 2036
(12 years from now) | |
| US11590088 | DERMAVANT SCI | Use of Tapinarof for the treatment of chronic plaque psoriasis |
Nov, 2039
(15 years from now) | |
Vtama is owned by Dermavant Sci.
Vtama contains Tapinarof.
Vtama has a total of 9 drug patents out of which 0 drug patents have expired.
Vtama was authorised for market use on 23 May, 2022.
Vtama is available in cream;topical dosage forms.
Vtama can be used as topical treatment of plaque psoriasis in adults.
Drug patent challenges can be filed against Vtama from 23 May, 2026.
The generics of Vtama are possible to be released after 13 November, 2039.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | May 23, 2027 |
Drugs and Companies using TAPINAROF ingredient
NCE-1 date: 23 May, 2026
Market Authorisation Date: 23 May, 2022
Treatment: Topical treatment of plaque psoriasis in adults
Dosage: CREAM;TOPICAL
VTAMA family patents
